-
Trials and tribulations of conducting medication trials: pediatric bipolar disorder as prototype
Mani Pavuluri
Editorial: Clinical Investigation
-
Trials and tribulations of conducting medication trials: pediatric bipolar disorder as prototype
Mani Pavuluri
Editorial: Clinical Investigation
-
Trials and tribulations of conducting medication trials: pediatric bipolar disorder as prototype
Mani Pavuluri
Editorial: Clinical Investigation
-
Trials and tribulations of conducting medication trials: pediatric bipolar disorder as prototype
Mani Pavuluri
Editorial: Clinical Investigation
-
Trials and tribulations of conducting medication trials: pediatric bipolar disorder as prototype
Mani Pavuluri
Editorial: Clinical Investigation
-
Trials and tribulations of conducting medication trials: pediatric bipolar disorder as prototype
Mani Pavuluri
Editorial: Clinical Investigation
-
Trials and tribulations of conducting medication trials: pediatric bipolar disorder as prototype
Mani Pavuluri
Editorial: Clinical Investigation
-
Trials and tribulations of conducting medication trials: pediatric bipolar disorder as prototype
Mani Pavuluri
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation